Perforin-1 (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Perforin-1" in English language version.

refsWebsite

Global rank English rank

29nih.gov

4^th place

17doi.org

2^nd place

2ensembl.org

1,626^th place

1,007^th place

2harvard.edu

18^th place

17^th place

2semanticscholar.org

11^th place

8^th place

doi.org (Global: 2^nd place; English: 2^nd place)

Voskoboinik I, Trapani JA (December 2013). "Perforinopathy: a spectrum of human immune disease caused by defective perforin delivery or function". Frontiers in Immunology. 4: 441. doi:10.3389/fimmu.2013.00441. PMC 3860100. PMID 24376445.
Brennan AJ, Chia J, Trapani JA, Voskoboinik I (April 2010). "Perforin deficiency and susceptibility to cancer". Cell Death and Differentiation. 17 (4): 607–615. doi:10.1038/cdd.2009.212. PMID 20075937.
Osińska I, Popko K, Demkow U (2014). "Perforin: an important player in immune response". Central-European Journal of Immunology. 39 (1): 109–15. doi:10.5114/ceji.2014.42135. PMC 4439970. PMID 26155110.
Ivanova ME, Lukoyanova N, Malhotra S, Topf M, Trapani JA, Voskoboinik I, et al. (February 2022). "The pore conformation of lymphocyte perforin". Science Advances. 8 (6): eabk3147. doi:10.1126/sciadv.abk3147. PMC 8836823. PMID 35148176.{{cite journal}}: CS1 maint: article number as page number (link)
Tschopp J, Masson D, Stanley KK (1986). "Structural/functional similarity between proteins involved in complement- and cytotoxic T-lymphocyte-mediated cytolysis". Nature. 322 (6082): 831–834. Bibcode:1986Natur.322..831T. doi:10.1038/322831a0. PMID 2427956. S2CID 4330219.
Rosado CJ, Buckle AM, Law RH, Butcher RE, Kan WT, Bird CH, et al. (September 2007). "A common fold mediates vertebrate defense and bacterial attack". Science. 317 (5844): 1548–1551. Bibcode:2007Sci...317.1548R. doi:10.1126/science.1144706. PMID 17717151. S2CID 20372720.
Pipkin ME, Lieberman J (June 2007). "Delivering the kiss of death: progress on understanding how perforin works". Current Opinion in Immunology. Lymphocyte activation/Lymphocyte effector functions. 19 (3): 301–308. doi:10.1016/j.coi.2007.04.011. PMC 11484871. PMID 17433871.
Trapani JA (December 1995). "Target cell apoptosis induced by cytotoxic T cells and natural killer cells involves synergy between the pore-forming protein, perforin, and the serine protease, granzyme B". Australian and New Zealand Journal of Medicine. 25 (6): 793–799. doi:10.1111/j.1445-5994.1995.tb02883.x. PMID 8770355.
Froelich CJ, Orth K, Turbov J, Seth P, Gottlieb R, Babior B, et al. (November 1996). "New paradigm for lymphocyte granule-mediated cytotoxicity. Target cells bind and internalize granzyme B, but an endosomolytic agent is necessary for cytosolic delivery and subsequent apoptosis". The Journal of Biological Chemistry. 271 (46): 29073–29079. doi:10.1074/jbc.271.46.29073. PMID 8910561.
Thiery J, Keefe D, Boulant S, Boucrot E, Walch M, Martinvalet D, et al. (June 2011). "Perforin pores in the endosomal membrane trigger the release of endocytosed granzyme B into the cytosol of target cells". Nature Immunology. 12 (8): 770–777. doi:10.1038/ni.2050. PMC 3140544. PMID 21685908.
Sieni E, Cetica V, Hackmann Y, Coniglio ML, Da Ros M, Ciambotti B, et al. (April 2014). "Familial hemophagocytic lymphohistiocytosis: when rare diseases shed light on immune system functioning". Frontiers in Immunology. 5: 167. doi:10.3389/fimmu.2014.00167. PMC 3997030. PMID 24795715.
Gholam C, Grigoriadou S, Gilmour KC, Gaspar HB (March 2011). "Familial haemophagocytic lymphohistiocytosis: advances in the genetic basis, diagnosis and management". Clinical and Experimental Immunology. 163 (3): 271–283. doi:10.1111/j.1365-2249.2010.04302.x. PMC 3048610. PMID 21303357.
Risma K, Jordan MB (February 2012). "Hemophagocytic lymphohistiocytosis: updates and evolving concepts". Current Opinion in Pediatrics. 24 (1): 9–15. doi:10.1097/MOP.0b013e32834ec9c1. PMID 22189397.
Guan X, Guo H, Guo Y, Han Q, Li Z, Zhang C (July 2024). "Perforin 1 in Cancer: Mechanisms, Therapy, and Outlook". Biomolecules. 14 (8): 910. doi:10.3390/biom14080910. PMC 11352983. PMID 39199299.
Tuomela K, Ambrose AR, Davis DM (2022). "Escaping Death: How Cancer Cells and Infected Cells Resist Cell-Mediated Cytotoxicity". Frontiers in Immunology. 13 867098. doi:10.3389/fimmu.2022.867098. PMC 8984481. PMID 35401556.
Cullen SP, Brunet M, Martin SJ (April 2010). "Granzymes in cancer and immunity". Cell Death and Differentiation. 17 (4): 616–23. doi:10.1038/cdd.2009.206. PMID 20075940.
Andrin C, Pinkoski MJ, Burns K, Atkinson EA, Krahenbuhl O, Hudig D, et al. (July 1998). "Interaction between a Ca2+-binding protein calreticulin and perforin, a component of the cytotoxic T-cell granules". Biochemistry. 37 (29): 10386–10394. doi:10.1021/bi980595z. PMID 9671507.

ensembl.org (Global: 1,626^th place; English: 1,007^th place)

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000180644 – Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000037202 – Ensembl, May 2017

harvard.edu (Global: 18^th place; English: 17^th place)

ui.adsabs.harvard.edu

Tschopp J, Masson D, Stanley KK (1986). "Structural/functional similarity between proteins involved in complement- and cytotoxic T-lymphocyte-mediated cytolysis". Nature. 322 (6082): 831–834. Bibcode:1986Natur.322..831T. doi:10.1038/322831a0. PMID 2427956. S2CID 4330219.
Rosado CJ, Buckle AM, Law RH, Butcher RE, Kan WT, Bird CH, et al. (September 2007). "A common fold mediates vertebrate defense and bacterial attack". Science. 317 (5844): 1548–1551. Bibcode:2007Sci...317.1548R. doi:10.1126/science.1144706. PMID 17717151. S2CID 20372720.

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

Voskoboinik I, Trapani JA (December 2013). "Perforinopathy: a spectrum of human immune disease caused by defective perforin delivery or function". Frontiers in Immunology. 4: 441. doi:10.3389/fimmu.2013.00441. PMC 3860100. PMID 24376445.
Brennan AJ, Chia J, Trapani JA, Voskoboinik I (April 2010). "Perforin deficiency and susceptibility to cancer". Cell Death and Differentiation. 17 (4): 607–615. doi:10.1038/cdd.2009.212. PMID 20075937.
Osińska I, Popko K, Demkow U (2014). "Perforin: an important player in immune response". Central-European Journal of Immunology. 39 (1): 109–15. doi:10.5114/ceji.2014.42135. PMC 4439970. PMID 26155110.
Ivanova ME, Lukoyanova N, Malhotra S, Topf M, Trapani JA, Voskoboinik I, et al. (February 2022). "The pore conformation of lymphocyte perforin". Science Advances. 8 (6): eabk3147. doi:10.1126/sciadv.abk3147. PMC 8836823. PMID 35148176.{{cite journal}}: CS1 maint: article number as page number (link)
Tschopp J, Masson D, Stanley KK (1986). "Structural/functional similarity between proteins involved in complement- and cytotoxic T-lymphocyte-mediated cytolysis". Nature. 322 (6082): 831–834. Bibcode:1986Natur.322..831T. doi:10.1038/322831a0. PMID 2427956. S2CID 4330219.
Rosado CJ, Buckle AM, Law RH, Butcher RE, Kan WT, Bird CH, et al. (September 2007). "A common fold mediates vertebrate defense and bacterial attack". Science. 317 (5844): 1548–1551. Bibcode:2007Sci...317.1548R. doi:10.1126/science.1144706. PMID 17717151. S2CID 20372720.
Pipkin ME, Lieberman J (June 2007). "Delivering the kiss of death: progress on understanding how perforin works". Current Opinion in Immunology. Lymphocyte activation/Lymphocyte effector functions. 19 (3): 301–308. doi:10.1016/j.coi.2007.04.011. PMC 11484871. PMID 17433871.
Trapani JA (December 1995). "Target cell apoptosis induced by cytotoxic T cells and natural killer cells involves synergy between the pore-forming protein, perforin, and the serine protease, granzyme B". Australian and New Zealand Journal of Medicine. 25 (6): 793–799. doi:10.1111/j.1445-5994.1995.tb02883.x. PMID 8770355.
Froelich CJ, Orth K, Turbov J, Seth P, Gottlieb R, Babior B, et al. (November 1996). "New paradigm for lymphocyte granule-mediated cytotoxicity. Target cells bind and internalize granzyme B, but an endosomolytic agent is necessary for cytosolic delivery and subsequent apoptosis". The Journal of Biological Chemistry. 271 (46): 29073–29079. doi:10.1074/jbc.271.46.29073. PMID 8910561.
Thiery J, Keefe D, Boulant S, Boucrot E, Walch M, Martinvalet D, et al. (June 2011). "Perforin pores in the endosomal membrane trigger the release of endocytosed granzyme B into the cytosol of target cells". Nature Immunology. 12 (8): 770–777. doi:10.1038/ni.2050. PMC 3140544. PMID 21685908.
Sieni E, Cetica V, Hackmann Y, Coniglio ML, Da Ros M, Ciambotti B, et al. (April 2014). "Familial hemophagocytic lymphohistiocytosis: when rare diseases shed light on immune system functioning". Frontiers in Immunology. 5: 167. doi:10.3389/fimmu.2014.00167. PMC 3997030. PMID 24795715.
Gholam C, Grigoriadou S, Gilmour KC, Gaspar HB (March 2011). "Familial haemophagocytic lymphohistiocytosis: advances in the genetic basis, diagnosis and management". Clinical and Experimental Immunology. 163 (3): 271–283. doi:10.1111/j.1365-2249.2010.04302.x. PMC 3048610. PMID 21303357.
Risma K, Jordan MB (February 2012). "Hemophagocytic lymphohistiocytosis: updates and evolving concepts". Current Opinion in Pediatrics. 24 (1): 9–15. doi:10.1097/MOP.0b013e32834ec9c1. PMID 22189397.
Guan X, Guo H, Guo Y, Han Q, Li Z, Zhang C (July 2024). "Perforin 1 in Cancer: Mechanisms, Therapy, and Outlook". Biomolecules. 14 (8): 910. doi:10.3390/biom14080910. PMC 11352983. PMID 39199299.
Tuomela K, Ambrose AR, Davis DM (2022). "Escaping Death: How Cancer Cells and Infected Cells Resist Cell-Mediated Cytotoxicity". Frontiers in Immunology. 13 867098. doi:10.3389/fimmu.2022.867098. PMC 8984481. PMID 35401556.
Cullen SP, Brunet M, Martin SJ (April 2010). "Granzymes in cancer and immunity". Cell Death and Differentiation. 17 (4): 616–23. doi:10.1038/cdd.2009.206. PMID 20075940.
Andrin C, Pinkoski MJ, Burns K, Atkinson EA, Krahenbuhl O, Hudig D, et al. (July 1998). "Interaction between a Ca2+-binding protein calreticulin and perforin, a component of the cytotoxic T-cell granules". Biochemistry. 37 (29): 10386–10394. doi:10.1021/bi980595z. PMID 9671507.

ncbi.nlm.nih.gov

"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
Voskoboinik I, Trapani JA (December 2013). "Perforinopathy: a spectrum of human immune disease caused by defective perforin delivery or function". Frontiers in Immunology. 4: 441. doi:10.3389/fimmu.2013.00441. PMC 3860100. PMID 24376445.
Osińska I, Popko K, Demkow U (2014). "Perforin: an important player in immune response". Central-European Journal of Immunology. 39 (1): 109–15. doi:10.5114/ceji.2014.42135. PMC 4439970. PMID 26155110.
Ivanova ME, Lukoyanova N, Malhotra S, Topf M, Trapani JA, Voskoboinik I, et al. (February 2022). "The pore conformation of lymphocyte perforin". Science Advances. 8 (6): eabk3147. doi:10.1126/sciadv.abk3147. PMC 8836823. PMID 35148176.{{cite journal}}: CS1 maint: article number as page number (link)
"Entrez Gene: PRF1 perforin 1 (pore forming protein)".
Pipkin ME, Lieberman J (June 2007). "Delivering the kiss of death: progress on understanding how perforin works". Current Opinion in Immunology. Lymphocyte activation/Lymphocyte effector functions. 19 (3): 301–308. doi:10.1016/j.coi.2007.04.011. PMC 11484871. PMID 17433871.
Thiery J, Keefe D, Boulant S, Boucrot E, Walch M, Martinvalet D, et al. (June 2011). "Perforin pores in the endosomal membrane trigger the release of endocytosed granzyme B into the cytosol of target cells". Nature Immunology. 12 (8): 770–777. doi:10.1038/ni.2050. PMC 3140544. PMID 21685908.
Sieni E, Cetica V, Hackmann Y, Coniglio ML, Da Ros M, Ciambotti B, et al. (April 2014). "Familial hemophagocytic lymphohistiocytosis: when rare diseases shed light on immune system functioning". Frontiers in Immunology. 5: 167. doi:10.3389/fimmu.2014.00167. PMC 3997030. PMID 24795715.
Gholam C, Grigoriadou S, Gilmour KC, Gaspar HB (March 2011). "Familial haemophagocytic lymphohistiocytosis: advances in the genetic basis, diagnosis and management". Clinical and Experimental Immunology. 163 (3): 271–283. doi:10.1111/j.1365-2249.2010.04302.x. PMC 3048610. PMID 21303357.
Guan X, Guo H, Guo Y, Han Q, Li Z, Zhang C (July 2024). "Perforin 1 in Cancer: Mechanisms, Therapy, and Outlook". Biomolecules. 14 (8): 910. doi:10.3390/biom14080910. PMC 11352983. PMID 39199299.
Tuomela K, Ambrose AR, Davis DM (2022). "Escaping Death: How Cancer Cells and Infected Cells Resist Cell-Mediated Cytotoxicity". Frontiers in Immunology. 13 867098. doi:10.3389/fimmu.2022.867098. PMC 8984481. PMID 35401556.

semanticscholar.org (Global: 11^th place; English: 8^th place)

api.semanticscholar.org

Tschopp J, Masson D, Stanley KK (1986). "Structural/functional similarity between proteins involved in complement- and cytotoxic T-lymphocyte-mediated cytolysis". Nature. 322 (6082): 831–834. Bibcode:1986Natur.322..831T. doi:10.1038/322831a0. PMID 2427956. S2CID 4330219.
Rosado CJ, Buckle AM, Law RH, Butcher RE, Kan WT, Bird CH, et al. (September 2007). "A common fold mediates vertebrate defense and bacterial attack". Science. 317 (5844): 1548–1551. Bibcode:2007Sci...317.1548R. doi:10.1126/science.1144706. PMID 17717151. S2CID 20372720.

Perforin-1 (English Wikipedia)

doi.org (Global: 2nd place; English: 2nd place)

ensembl.org (Global: 1,626th place; English: 1,007th place)